Work

Hepatocyte Loss of TRMT61A Aggravates Liver Fibrosis by Driving ATF3‐Mediated Apoptosis and Macrophage Recruitment

Year: 2026
Type: article
Abstract: Liver fibrosis is a common pathological consequence of chronic liver injury, but the hepatocyte‐intrinsic mechanisms that initiate fibrogenic remodeling of the hepatic microenvironment remain incompletely defined. Here, we identify the RNA methyltransferase TRMT61A as a hepatocyte protective factor that is reduced in human fibrotic liver tissues and in experimental mouse models of liver fibrosis. Hepatocyte‐specific deletion of Trmt61a was sufficient to trigger liver injury and progressive fibrosis, whereas restoration of enzymatically active TRMT61A restored m 1 A modification and ameliorated fibrosis. Mechanistically, Trmt61a deficiency activated the integrated stress response (ISR) marked by eIF2α phosphorylation and ATF3 induction, promoting hepatocyte apoptosis and CCL2 production. Transcriptomic and single‐cell analyses revealed profound remodeling of the hepatic immune microenvironment, characterized by loss of embryonically derived Kupffer cells and accumulation of CCR2‐positive monocyte‐derived macrophages with pro‐fibrotic inflammatory programs. Pharmacological CCR2/CCR5 blockade with cenicriviroc or hepatic Atf3 knockdown reduced macrophage infiltration and attenuated fibrosis in Trmt61a ‐deficient mice. These findings underscore the pivotal role of TRMT61A in regulating hepatocyte fate and remodeling the hepatic immune microenvironment during fibrosis progression, with the ISR–ATF3 axis serving as a central mechanistic hub. Restoring TRMT61A activity in hepatocytes thus represents a promising therapeutic strategy for preserving hepatocyte function and counteracting liver fibrosis.
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: gold
Estimated APC paid: $6,730
OpenAlex ID: W7236800799
FWCI:
Cites: 54
Cited by:
Related to: 10